Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Baxter
Citi
Moodys
Novartis
UBS
Medtronic
Argus Health
Cipla
AstraZeneca

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,464,933

« Back to Dashboard

Summary for Patent: 5,464,933
Title: Synthetic peptide inhibitors of HIV transmission
Abstract:The present invention relates to peptides which exhibit potent anti-retroviral activity. The peptides of the invention comprise DP-178 (SEQ ID:1) ptides corresponding to amino acids 638 to 673 of the HIV-1.sub.LAI gp41 protein, and fragments, analogs and homologs of DP-178. The invention further relates to the uses of such peptides as inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells.
Inventor(s): Bolognesi; Dani P. (Durham, NC), Matthews; Thomas J. (Durham, NC), Wild; Carl T. (Durham, NC)
Assignee: Duke University (Durham, NC)
Application Number:08/073,028
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 5,464,933

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,464,933

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 293127 ➤ Try a Free Trial
Austria 308558 ➤ Try a Free Trial
Australia 4473496 ➤ Try a Free Trial
Australia 692777 ➤ Try a Free Trial
Australia 7042694 ➤ Try a Free Trial
Australia 714695 ➤ Try a Free Trial
Canada 2164698 ➤ Try a Free Trial
Canada 2208420 ➤ Try a Free Trial
Chile 2004001413 ➤ Try a Free Trial
Germany 122005000025 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
US Army
Deloitte
Cerilliant
Federal Trade Commission
Chubb
Baxter
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot